To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Already have an account?
Scaffdex Oy and Conmed Linvatec Biomaterials Sign a Licensing Agreement of Commercialization and Clinical Data of Joint Prosthesis Innovation
Read time: Less than a minute
Scaffdex Oy and Conmed Linvatec Biomaterials have signed a licensing agreement of commercialization and clinical data of joint prosthesis innovation. Target of Scaffdex Oy is CE marking and launch of this product by end of 2010.
Joint prosthesis replaces small joints in hand and foot and it has been tested clinically for example in rheumatoid arthritis patients. Tampere University Hospital, Hospital of Foundation of Rheumatoid Arthritis in Heinola and clinics in Germany and Italy participated these international clinical trials.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
